Nanoparticle-drug conjugates treating bacterial infections

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Infectious Diseases

Background:

• Antibiotic resistance is a growing global health crisis.
• Conventional antibiotics are losing efficacy against pathogenic bacteria.
• Novel therapeutic strategies are urgently needed to combat resistant infections.

Purpose of the Study:

• To review nanoparticle-drug conjugates for treating bacterial infections.
• To explore the role of nanoparticles in enhancing antimicrobial therapy.
• To summarize synthesis methods and applications of these conjugates.

Main Methods:

• Literature review of studies on nanoparticle-drug conjugates.
• Analysis of nanoparticle roles: carrier, synergistic agent, theranostic agent.
• Examination of synthesis methodologies and reported applications.

Main Results:

• Nanoparticle-drug conjugates show significant activity against pathogenic bacteria.
• Nanoparticles enhance bacterial cell membrane permeability, increasing antibiotic uptake.
• Conjugates demonstrate efficacy in killing antibiotic-resistant bacterial strains.

Conclusions:

• Nanoparticle-drug conjugates are a viable strategy to overcome antibiotic resistance.
• Further advancements in nanoparticle-drug conjugates are necessary for improved therapeutic proficiency.
• These conjugates hold potential for enhanced treatment of bacterial infections.